Pharmacokinetics of the combination of fluvastatin and gemfibrozil-Reference-Cited by-同舟云学术

Pharmacokinetics of the combination of fluvastatin and gemfibrozil

Published:1995-07 Issue:1-2 Volume:76 Page:80A-83A
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

David Spence J.,Munoz Claudio E.,Hendricks Lisa,Latchinian Lilian,Khouri Henry E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. The Lipid Research Clinics Coronary Primary Prevention Trial Results I. Reduction in incidence of coronary heart disease;Lipid Research Clinics Program;JAMA,1984

2. The Lipid Research Clinics Coronary Primary Prevention Trial Results II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering;Lipid Research Clinics Program;JAMA,1984

3. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease;Frick;New Engl J Med,1987

4. Clinical implications of new drugs for lowering plasma cholesterol concentrations;Illingworth;Drugs,1991

5. Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins;Zimetbaum;J Clin Pharmacol,1991

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and characterization of novel functional polyesters containing chromone curcumin units and evaluation of its anticancer potential-An in vitro and in silico approach;Journal of Saudi Chemical Society;2024-05

2. Rottlerin renders a selective and highly potent CYP2C8 inhibition to impede EET formation for implication in cancer therapy;Chemico-Biological Interactions;2023-08

3. An Improved Method for Cytochrome P450 Reaction Phenotyping Using a Sequential Qualitative-Then-Quantitative Approach;Drug Metabolism and Disposition;2022-07-01

4. Effect of Myricetin on CYP2C8 Inhibition to Assess the Likelihood of Drug Interaction Using In Silico, In Vitro, and In Vivo Approaches;ACS Omega;2022-04-04

5. Case Study 7: Transporters —In Vitro Solutions for Translatable Outcomes;Methods in Molecular Biology;2021